Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-11-16
pubmed:abstractText
Surgery remains the mainstay of treatment for colon cancer and surgical resection alone results in 5-year survival in more than 60% of patients. However, the use of fluorouracil (5-FU)-based adjuvant chemotherapy for patients at high risk of recurrence further prolongs disease-free survival and has become the standard of care. New areas of research focus on decreasing the surgical trauma with minimally invasive approaches, improving the surgical staging of patients with colon cancer, and improving adjuvant treatment regimens. We review those randomized controlled trials that have most impacted the clinical management of patients with colon cancer in 2009.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1558-5042
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
183-204
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Randomized clinical trials in colon cancer.
pubmed:affiliation
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, H1206, New York, NY 10065, USA. neuman@surgery.wisc.edu
pubmed:publicationType
Journal Article, Review